ChitogenX (CHNXF)
OTHER OTC:CHNXF
CHNXF Stock Chart & Stats
$0.01
<$0.01(20.00%)
At close: 4:00 PM EST
$0.01
<$0.01(20.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume39.22K
Average Volume (3M)3.00
Market Cap
$293.86K
Enterprise Value$4.26M
Total Cash (Recent Filing)$48.00K
Total Debt (Recent Filing)$4.23M
Price to Earnings (P/E)―
Beta-2.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding83,129,520
10 Day Avg. Volume0
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-1.00
Price to Sales (P/S)0.00
P/FCF Ratio-6.15
Enterprise Value/Market Cap14.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-236.42
Enterprise Value/Ebitda-3.57
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ChitogenX News
CHNXF FAQ
What was ChitogenX’s price range in the past 12 months?
ChitogenX lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is ChitogenX’s market cap?
ChitogenX’s market cap is $293.86K.
When is ChitogenX’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ChitogenX’s earnings last quarter?
Currently, no data Available
Is ChitogenX overvalued?
According to Wall Street analysts ChitogenX’s price is currently Overvalued.
Does ChitogenX pay dividends?
ChitogenX does not currently pay dividends.
What is ChitogenX’s EPS estimate?
ChitogenX’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ChitogenX have?
ChitogenX has 83,129,520 shares outstanding.
What happened to ChitogenX’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ChitogenX?
Currently, no hedge funds are holding shares in CHNXF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ChitogenX
ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.
Technical Analysis
Covalon Technologies
―
Hemostemix
―
Kane Biotech
―
Microbix Biosystms
―
Quest Pharmatech
―